Variables | Univariate analyses | Multivariate analyses | ||
---|---|---|---|---|
HR (95%CI) | P Value | HR (95%CI) | P Value | |
Age | 1.044 (0.978–1.114) | 0.199 |  |  |
Sex | 5.645 (0.658–48.423) | 0.115 |  |  |
BMI | 1.109 (0.959–1.283) | 0.163 | 0.954 (0.747–1.219) | 0.708 |
Smoking | 2.390 (0.437–13.068) | 0.315 |  |  |
Hypertension | 4.092 (0.749–22.351) | 0.104 | 1.614 (0.209–12.480) | 0.647 |
Hypercholesterolemia | 7.349 (1.481–36.472) | 0.015* | 41.826 (2.188-799.396) | 0.013* |
Diabetes | 25.648 (2.993–219.82) | 0.003* | 26.938 (1.779–407.820) | 0.018* |
Primary symptom (%) | Â | Â | Â | Â |
 Infarction | 1.568 (0.316–7.771) | 0.582 |  |  |
 Non-infarction | Reference | - |  |  |
Laboratory results | Â | Â | Â | Â |
 WBC count, 109/L | 1.483 (1.203–1.828) | < 0.05* |  |  |
 LY count, 109/L | 0.863 (0.254–2.928) | 0.813 |  |  |
 PLT count, 109/L | 1.007 (0.998–1.016) | 0.114 |  |  |
 Cr, µmol/L | 1.038 (0.995–1.083) | 0.085 |  |  |
 UA, µmol/L | 0.999 (0.991–1.008) | 0.859 |  |  |
 ALT, U/L | 1.016 (0.991–1.042) | 0.212 |  |  |
 HDL, mmol/L | 0.247 (0.015–4.063) | 0.328 | 1.259 (0.080-19.715) | 0.870 |
 LDL, mmol/L | 0.639 (0.221–1.849) | 0.409 |  |  |
 TG, mmol/L | 1.505 (0.723–3.133) | 0.274 |  |  |
 TC, mmol/L | 0.586 (0.234–1.470) | 0.255 |  |  |
 GGT, mmol/L | 0.996 (0.952–1.041) | 0.844 | 0.930 (0.834–1.036) | 0.185 |
 HCY, µmol/L | 1.037 (0.958–1.122) | 0.370 |  |  |
 ApoA, g/L | 0.783 (0.043–14.230) | 0.869 |  |  |
 ApoB, g/L | 0.42 (0.009–21.294) | 0.669 |  |  |
Suzuki stage, n (%) | Â | Â | Â | Â |
 1–3 | Reference | - |  |  |
 4–6 | 0.994 (0.465–2.124) | 0.987 |  |  |
Surgical option (%) | Â | Â | Â | Â |
 Indirect bypass | Reference | - | Reference | - |
 Direct bypass | 0.561 (0.103–3.065) | 0.505 | 0.048 (0.002–1.113) | 0.058 |
NAFLD | 8.066 (1.474–44.134) | 0.016* | 10.815 (1.259–92.881) | 0.030* |